Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists

European Journal of Pharmacology

Volumn 460, Issue 1, 2003, Pages 75-83

  Landgraf, Richardt Gama ^a   Sirois, Pierre ^b   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Airway inflammation; Asthma; Bradykinin; Bradykinin receptor antagonist; Eosinophil

Indexed keywords

BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; CD4 ANTIGEN; CD8 ANTIGEN; ICATIBANT; OVALBUMIN; R 954; UNCLASSIFIED DRUG;

ALLERGIC PNEUMONITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; HISTOPATHOLOGY; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; MOUSE; MUCUS SECRETION; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RODENT; SUPPRESSOR CELL;

EID: 0037466839     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02880-7     Document Type: Article

References (35)

1. Barnes P.J. Bradykinin and asthma. Thorax. 47:1992;979-983.
2. Barnes P.J., Fan Chung K., Page C.P. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:1998;515-596.
3. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 15:1997;535-562.
4. Cassim B., Naidoo S., Ramsaroop R., Bhoola K.D. Immunolocalization of bradykinin receptors on human synovial tissue. Immunopharmacology. 36:1997;121-125.
5. Christiansen S.C., Proud D., Sarnoff R.B., Juergens U., Cochrane C.G., Zuran B.L. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am. Rev. Respir. Dis. 145:1992;900-905.
6. Cohn L., Ray A. T-helper type 2 cell-directed therapy for asthma. Pharmacol. Ther. 88:2000;187-196.
7. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429:2001;161-176.
8. Eich-Rathfelder S., Whalley E.T., Fautz M., Hohenbleicher F., Fritz H., Siebeck M. Tachyphylaxis of the B1 kinin receptor in porcine endotoxin shock. Immunopharmacology. 36:1997;173-177.
9. Eric J., Bkaily G., Volkov L., Sirois P. Expression du récepteur B1 de la bradykinine dans l'asthme. Méd. Sci. 16(2):2000;28.
10. Farmer S.G., Wilkins D.E., Meeker S.A., Seeds E.A., Page C.P. Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyper-responsiveness and eosinophilia in guinea-pigs. Br. J. Pharmacol. 107:1992;653-659.
11. Fechter M., Egger D., Aver H. Experimental eosinophilia and inflammation. The effect of various inflammatory mediators and chemoattractants. Exp. Pathol. 29:1986;153-158.
12. Ferreira H.H.A., Medeiros M.V., Lima C.S.P., Flores C.A., Sannomiya P., Antunes E., De Nucci G. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. Eur. J. Pharmacol. 310:1996;201-207.
13. Fuller R.W., Dixon C.M., Cuss F.M., Barnes P.J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am. Rev. Respir. Dis. 135:1987;176-180.
14. 2 and thromboxane receptors. Am. J. Respir. Crit. Care Med. 150:1994;1012-1018.
15. Korsgren M., Persson C.G.A., Sundler F., Bjerke T., Hansson T., Chambers B.J., Hong S., Kaer L.V., Ljunggren H.G., Korsgren O. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189:1999;553-562.
16. 1 receptors for kinins. Pharmacol. Rev. 50:1998;357-386.
17. Mashito Y., Ichinose M., Shirato K. Bradykinin B2 antagonist HOE 140 inhibits late allergic microvascular leakage in guinea pig airways. Immunopharmacology. 43(2-3):1999;249-253.
18. Medzhitov R., Janeway C.A. Jr. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:1997;4-9.
19. Molimard M., Martin C.A.E., Naline E., Hirsch A., Advenier C. Contractile effects of bradykinin on the isolated human bronchus. Am. J. Respir. Crit. Care Med. 149:1994;123-127.
20. Nakanish S. Substance P precursor and kininogen: their structures, gene organizations and regulation. Physiol. Rev. 67:1987;1117-1142.
21. Pasquale C.P., Martins M.A., Bozza P.T., Silva P.M., Faria Neto H.C., Pires A.L., Cordeiro R.S. Bradykinin induces eosinophil accumulation in the rat pleural cavity. Int. Arch. Allergy Appl. Immunol. 95:1991;244-247.
22. Perron M.S., Gobeil F., Pelletier S., Regoli D., Sirois P. Involvement of bradykinin B1 and B2 receptors in pulmonary leukocyte accumulation induced by Sephadex beads in guinea pigs. Eur. J. Pharmacol. 376:1999;83-89.
23. Polosa R., Holgate S.T. Comparative airway responses to inhaled bradykinin, kallidin and [des-Arg9]-bradykinin in normal and asthmatic airways. Am. Rev. Respir. Dis. 142:1990;1367-1371.
24. Proud D., Kaplan A.P. Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol. 6:1988;49-83.
25. Prussin C., Foster B. TCR Vα24 and Vβ11 co-expression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159:1997;5862-5870.
26. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
27. Regoli D., Rizzi A., Calo G., Allogho S.N., Gobeil F. B1 and B2 kinin receptors in various species. Immunopharmacology. 36:1997;143-147.
28. Soler M., Sielezak M., Abraham W.M. A bradykinin receptor antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm. Pharmacol. 3:1990;9-15.
29. Spinozzi F., Agea E., Bistoni O., Forenza N., Bertotto A. γδ T cells, allergen recognition and airway inflammation. Immunol. Today. 19:1998;22-26.
30. Strath M., Warren D.J., Sanderson C.J. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods. 83:1985;209-215.
31. Vesterinen E., Timonen T. Natural killer cell activity in specific and non-specific bronchial challenge. Ann. Allergy. 60:1988;247-249.
32. Walker C., Kaegi M.K., Braun P., Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:1991;935-942.
33. Weissler J.C., Nicod L.P., Lipscomb M.F., Toews G.B. Natural killer cell function in human lung is compartmentalized. Am. Rev. Respir. Dis. 135:1987;941-949.
34. Woisin F.E., Matsumoto T., Douglas G.J., Paul W., Whalley E.T., Page C.P. Effect of antagonists for NK2 and B2 receptors on antigen-induced airway responses in allergic rabbits. Pulm. Pharmacol. Ther. 13:2000;13-23.
35. Zuany-Amorim C., Ruffié C., Hailé S., Vargaftig B.B., Pereira P., Pretolani M. Requirement for γδ T cells in allergic airway inflammation. Science. 280:1998;1265-1267.